https://openbell.ai/ 2026-10-19T15:58:05.828Z hourly 1.0 https://openbell.ai/support 2026-10-19T15:58:05.828Z monthly 0.7 https://openbell.ai/privacy 2026-10-19T15:58:05.828Z monthly 0.5 https://openbell.ai/terms 2026-10-19T15:58:05.828Z monthly 0.5 https://openbell.ai/feed.json 2026-10-19T15:58:05.828Z hourly 0.8 https://openbell.ai/news/SNOW:1792425405048 2026-10-19T15:56:45.048Z daily 0.9 https://cdn.brandfetch.io/SNOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Snowflake Stock Surging Monday? Snowflake Inc. (NYSE: SNOW) stock rebounded by 3.30% to $316.97 on Monday after a selloff on Friday, as investors returned to technology stocks amidst broader market gains, with the Nasdaq Composite rising 1.59%. Despite concerns over rising debt levels and a Gartner report on neocloud providers, Wall Street analysts remain bullish, with 31 out of 35 recommending a Buy rating and an average price forecast of $402, indicating a potential upside of about 27%. Technical analysis shows the stock is in a long-term uptrend, trading 6.9% above its 100-day SMA, but faces near-term selling pressure, with key resistance at $348.50 and support at $317. https://openbell.ai/news/NFLX:1792425403217 2026-10-19T15:56:43.217Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 18 Globo Titles Heading To Netflix In Unprecedented Licensing Agreement Netflix has entered into a licensing agreement with Globo to stream 18 titles from the Brazilian media company. This unprecedented deal expands Netflix's content library and strengthens its position in the Latin American market. The specific financial terms of the agreement have not been disclosed, but it is expected to enhance subscriber engagement and attract new viewers. https://openbell.ai/news/IBRX:1792425143176 2026-10-19T15:52:23.176Z daily 0.9 https://cdn.brandfetch.io/IBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment ImmunityBio, Inc. (NASDAQ: IBRX) reported promising results from its Phase 2/3 QUILT-3.032 study of its immunotherapy treatment, ANKTIVA, showing a 71% complete response rate and a median response duration of 26.6 months for patients with BCG-unresponsive non-muscle invasive bladder cancer. The study also indicated an 84% cystectomy-free survival rate at 36 months and a 98.2% disease-specific survival rate at three years, with no severe treatment-related adverse events reported. ImmunityBio's stock has increased by 255.13% over the past year, trading at $9.609, up 4.68% on Monday. https://openbell.ai/news/VAI:1792425046909 2026-10-19T15:50:46.909Z daily 0.9 https://cdn.brandfetch.io/VAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Valor Energy shares are trading higher after the company announced that will acquire a 18MW computing center. openbell Financial News https://openbell.ai/news/TTMI:1792424968820 2026-10-19T15:49:28.820Z daily 0.9 https://cdn.brandfetch.io/TTMI/w/400/h/400?c=1idopYfmtR7ZKg8QMud TTM Technologies shares are trading higher after the company announced that it has entered into a definitive agreement to acquire the Ophir Optics business from MKS for approximately $650 million in an all-cash transaction. openbell Financial News https://openbell.ai/news/RKLB:1792424738453 2026-10-19T15:45:38.453Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/RocketLab.jpg?width=250&height=187 Rocket Lab Stock Climbs: What's Happening? Rocket Lab Corp (NASDAQ: RKLB) shares rose 3.34% to $52.54 following an Overweight rating from Cantor Fitzgerald, which maintained a price target of $122 despite a delay in the Neutron launch to 2027 due to production issues. The company is also pursuing a deal to acquire Iridium Communications Inc for $54 per share, which could potentially double Rocket Lab's revenue, with projections of $939.8 million for fiscal 2026. Analysts believe the revenue synergies from the Iridium acquisition have not yet been fully reflected in current estimates. https://openbell.ai/news/EXYN:1792424721999 2026-10-19T15:45:21.999Z daily 0.9 https://cdn.brandfetch.io/EXYN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Exyn Technologies shares are trading higher after the company announced that it joined a Department of Energy-backed mining project to hunt for critical metals. openbell Financial News https://openbell.ai/news/MU:1792424272952 2026-10-19T15:37:52.952Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Micron.jpg?width=250&height=187 Why Micron and Sandisk Stocks Are Surging Monday Micron Technology Inc. (NASDAQ: MU) and Sandisk Corp. (NASDAQ: SNDK) saw their stocks rise on Monday, with Micron up 5.13% to $923.93 and Sandisk up 7.56% to $1397.55, following a broader recovery in technology stocks after last week's selloff. Investors are regaining confidence amid strong demand for memory products used in AI data centers, despite previous concerns over competition from Chinese chipmaker ChangXin Memory Technologies. Analysts suggest that while AI demand supports growth, the memory sector faces challenges from moderating price increases and potential competition. https://openbell.ai/news/GPK:1792424209622 2026-10-19T15:36:49.622Z daily 0.9 https://cdn.brandfetch.io/GPK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Underweight on Graphic Packaging Holding, Lowers Price Target to $9 Wells Fargo analyst Richard Carlson has maintained an Underweight rating on Graphic Packaging Holding (NYSE: GPK) and has lowered the price target from $10 to $9. https://openbell.ai/news/NFLX:1792423900508 2026-10-19T15:31:40.508Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Dan Lin Out as Netflix Film Chief' - Variety Dan Lin is stepping down from his position as the head of Netflix's film division. His departure comes amid ongoing changes within the company as it seeks to adapt to a competitive streaming landscape. Netflix has not yet announced a successor or provided details on the reasons behind Lin's exit. https://openbell.ai/news/BTCUSD:1792423769422 2026-10-19T15:29:29.422Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Dalio--Dimon-Warn-Of-Debt-Crisis-And-Bon.jpg?width=250&height=187 Could Bitcoin's Next Big Catalyst Come From the $300 Trillion Bond Market? Bitcoin (BTC) may see growth as it targets the $300 trillion global bond market through BTC-backed credit products, according to Richard Byworth of BYZ Partners. Strategy (NASDAQ:MSTR) is launching perpetual preferred equity products that offer yields backed by Bitcoin-heavy corporate balance sheets. Byworth noted that several countries are considering Bitcoin-backed bonds for financing energy infrastructure, which could reduce reliance on traditional lenders. Currently, Bitcoin is consolidating around $82,000, with signs of selling pressure nearing exhaustion. https://openbell.ai/news/TRV:1792423673270 2026-10-19T15:27:53.270Z daily 0.9 https://cdn.brandfetch.io/TRV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Equal-Weight on Travelers Companies, Raises Price Target to $377 Wells Fargo analyst Elyse Greenspan has maintained an Equal-Weight rating on Travelers Companies (NYSE: TRV) and raised the price target from $341 to $377. This adjustment reflects a positive outlook for the company while keeping the stock rating unchanged. https://openbell.ai/news/TSCO:1792423586778 2026-10-19T15:26:26.778Z daily 0.9 https://cdn.brandfetch.io/TSCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Tractor Supply, Raises Price Target to $36 Wells Fargo analyst Zachary Fadem has maintained an Overweight rating on Tractor Supply Company (NASDAQ: TSCO) and has raised the price target from $35 to $36. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/MTCH:1792423288611 2026-10-19T15:21:28.611Z daily 0.9 https://cdn.brandfetch.io/MTCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Match Group shares are trading higher after Evercore ISI Group upgraded the stock from In-Line to Outperform and raise its price target from $39 to $53. openbell Financial News https://openbell.ai/news/ESLT:1792423142971 2026-10-19T15:19:02.971Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Elbit-Systems-Photo-by-T--Schneider-via-.jpg?width=250&height=187 Elbit Systems Secures $235 Million European Defense Deal Elbit Systems Ltd. has secured a $235 million contract to supply EXTRA-MR rockets and PULS rocket artillery systems to a European customer, under a government-to-government agreement. The three-year deal includes additional rocket artillery platforms and integrated logistics support. Following the announcement, Elbit's stock rose by 0.19% to $756.87, and the company has seen a 53.97% increase in stock value over the past year. https://openbell.ai/news/BTCUSD:1792423115168 2026-10-19T15:18:35.168Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Golden-Bitcoin-Coin-In-Red-And-Blue-Smok.jpg?width=250&height=187 'Of Course' Bitcoin Could Grow to $50 Trillion, Jordi Visser Says: But How? Macro investor Jordi Visser suggests that Bitcoin (BTC) could potentially reach a $50 trillion valuation, citing its recent performance as a safe asset amidst market volatility. He attributes the current market selloff to leveraged hedge funds rather than issues with AI stocks, noting that Bitcoin has maintained a trading range between $82,000 and $85,000 for four months. Visser anticipates significant movements in both AI stocks and Bitcoin following hyperscaler earnings reports later this month and again in December, as many funds reduce risk for the year. https://openbell.ai/news/EIDO:1792422912373 2026-10-19T15:15:12.373Z daily 0.9 https://cdn.brandfetch.io/EIDO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Indonesian companies are trading lower amid continued weakness after the MSCI recently launched a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. openbell Financial News https://openbell.ai/news/NVS:1792422799352 2026-10-19T15:13:19.352Z daily 0.9 https://cdn.brandfetch.io/NVS/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies The FDA has granted orphan drug designation to Novartis' Rapcabtagene Autoleucel for the treatment of idiopathic inflammatory myopathies. This designation is intended to encourage the development of treatments for rare diseases. The approval may impact Novartis' market position in the specialty pharmaceuticals sector, although specific financial implications were not detailed in the article. https://openbell.ai/news/UL:1792422764184 2026-10-19T15:12:44.184Z daily 0.9 https://cdn.brandfetch.io/UL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Unilever Agrees to Sell Welly Bandage Business to Private-Equity Firm' - WSJ Exclusive Unilever has agreed to sell its Welly bandage business to a private-equity firm, marking a strategic move to streamline its portfolio. The financial details of the transaction have not been disclosed. This divestiture aligns with Unilever's ongoing efforts to focus on its core brands and improve profitability. The sale reflects the company's strategy to enhance operational efficiency in a competitive market. https://openbell.ai/news/WORX:1792422615866 2026-10-19T15:10:15.866Z daily 0.9 https://cdn.brandfetch.io/WORX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SCWorx shares are trading higher after the company announced an agreement with a healthcare system to provide its healthcare supply chain data management services. openbell Financial News https://openbell.ai/news/CGEM:1792422562696 2026-10-19T15:09:22.696Z daily 0.9 https://cdn.brandfetch.io/CGEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Cullinan Therapeutics, Maintains $40 Price Target BTIG analyst Julian Harrison has reiterated a Buy rating on Cullinan Therapeutics (NASDAQ: CGEM) and has maintained a price target of $40 for the stock. This endorsement suggests confidence in the company's future performance. https://openbell.ai/news/SMMT:1792422515796 2026-10-19T15:08:35.796Z daily 0.9 https://cdn.brandfetch.io/SMMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Summit Therapeutics shares are trading higher after the company announced the initiation and opening of clinical trial sites of a multiregional Phase II study of ivonescimab. openbell Financial News https://openbell.ai/news/VAC:1792422451431 2026-10-19T15:07:31.431Z daily 0.9 https://cdn.brandfetch.io/VAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Underweight on Marriott Vacations, Lowers Price Target to $100 Wells Fargo analyst Trey Bowers has maintained an Underweight rating on Marriott Vacations (NYSE: VAC) and has lowered the price target from $101 to $100. This adjustment reflects the analyst's cautious outlook on the company's performance. https://openbell.ai/news/NVDA:1792422432671 2026-10-19T15:07:12.671Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA Advances Agentic Security For Media, From European Public Service Broadcasting To Global Content Production NVIDIA has announced advancements in agentic security aimed at enhancing media production, targeting both European public service broadcasting and global content production sectors. This initiative is expected to bolster content protection and streamline workflows in the media industry. The company's focus on security solutions aligns with its broader strategy to support content creators and distributors in an increasingly digital landscape. https://openbell.ai/news/AIBT:1792422414109 2026-10-19T15:06:54.109Z daily 0.9 https://cdn.brandfetch.io/AIBT/w/400/h/400?c=1idopYfmtR7ZKg8QMud AIBotics Acquires Operating Assets Associated With NovaCore Labs From PlayJamaica AIBotics, Inc. (OTCID: AIBT) has completed the acquisition of operating assets from NovaCore Labs, previously owned by PlayJamaica Limited, under an Asset Sale and Purchase Agreement. This acquisition aims to support AIBotics' expansion plans in Jamaica and the CARICOM region, which is projected to have a combined GDP of approximately US$420 billion and an average real GDP growth rate of 3.4% by 2026. https://openbell.ai/news/NVDA:1792422394307 2026-10-19T15:06:34.307Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA Advances Agentic Security For Media, From European Public Service Broadcasting To Global Content Production NVIDIA has introduced advancements in agentic security aimed at enhancing media production, specifically targeting European public service broadcasting and global content production. This initiative is part of NVIDIA's broader strategy to strengthen security measures in the media industry. The company continues to innovate in the field, positioning itself as a leader in providing secure solutions for content creators. https://openbell.ai/news/QQQ:1792422390297 2026-10-19T15:06:30.297Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Nvidia-Logo-On-Phone-And-Blurred-Ai-Chip.jpg?width=250&height=187 Nasdaq 100 Stocks Add Nearly $500 Billion As Chips Battle To Snap 2008-Style Rout The Nasdaq 100 saw an increase of nearly $500 billion in market value, with semiconductor stocks contributing approximately $270 billion to this rebound. The PHLX Semiconductor Index rose by 3.1% after a significant decline of 15.74% over eight consecutive sessions. Nvidia Corp. led the gains, adding $73.7 billion in market cap, while Amazon.com Inc. also rose about 4%, contributing over $100 billion. Analysts noted that semiconductor companies are experiencing strong order backlogs, with some customers placing orders as far out as 2029 and 2030. https://openbell.ai/news/MAR:1792422329826 2026-10-19T15:05:29.826Z daily 0.9 https://cdn.brandfetch.io/MAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Marriott International, Raises Price Target to $426 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on Marriott International (NASDAQ: MAR) and raised the price target from $425 to $426. This adjustment reflects the firm's positive outlook on the company's performance. https://openbell.ai/news/YMAT:1792422282856 2026-10-19T15:04:42.856Z daily 0.9 https://cdn.brandfetch.io/YMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud J-Star Holding shares are trading higher after the company announced progress on its planned US drone frame production initiative, including ongoing negotiations to acquire a commercial manufacturing facility in the Greater Houston area. openbell Financial News https://openbell.ai/news/EQPT:1792422221237 2026-10-19T15:03:41.237Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Campaign-Could-Spread.jpg?width=250&height=187 EquipmentShare Boosts 2026 Forecast As Rental Network Performance Improves EquipmentShare.com Inc. (NASDAQ: EQPT) has raised its 2026 financial guidance, now expecting total revenue between $5.81 billion and $6.05 billion, up from a previous range of $5.25 billion to $5.68 billion. The rental segment revenue is projected at $3.82 billion to $3.98 billion, with adjusted Core EBITDA anticipated to reach $2.14 billion to $2.22 billion. The company's shares rose by 6.07% to $14.41 following the announcement, driven by strong customer demand and fleet utilization across its rental network. https://openbell.ai/news/HLT:1792422156995 2026-10-19T15:02:36.995Z daily 0.9 https://cdn.brandfetch.io/HLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Hilton Worldwide Holdings, Raises Price Target to $383 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on Hilton Worldwide Holdings (NYSE: HLT) and raised the price target from $382 to $383. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ATNM:1792422019576 2026-10-19T15:00:19.576Z daily 0.9 https://cdn.brandfetch.io/ATNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Actinium Pharmaceuticals shares are trading higher ahead of presentations on Phase 1 ATNM-400 prostate cancer data and preclinical lung cancer findings at EANM 2026. openbell Financial News https://openbell.ai/news/MQ:1792421958163 2026-10-19T14:59:18.163Z daily 0.9 https://cdn.brandfetch.io/MQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier: Block Expands Marqeta Partnership To Power Square Credit Card On American Express Network, Consolidating Debit, Prepaid And Credit Programs On One Platform Marqeta has expanded its partnership with Block to power the Square Credit Card on the American Express Network, consolidating Square's debit, prepaid, and credit programs onto a single platform. This migration aims to reduce operational complexity and enhance the speed of introducing new credit features for sellers. The collaboration builds on their previous partnership initiated in 2019, which introduced the Square Card for small business owners, allowing immediate access to earnings without additional fees. https://openbell.ai/news/CLNN:1792421886493 2026-10-19T14:58:06.493Z daily 0.9 https://cdn.brandfetch.io/CLNN/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Clene (NASDAQ: CLNN) and maintained a price target of $31 for the company's stock. https://openbell.ai/news/ACTU:1792421722521 2026-10-19T14:55:22.521Z daily 0.9 https://cdn.brandfetch.io/ACTU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Actuate Therapeutics shares are trading higher after the company announced a public offering of 40 million shares and 20 million warrants. openbell Financial News https://openbell.ai/news/RRR:1792421565372 2026-10-19T14:52:45.372Z daily 0.9 https://cdn.brandfetch.io/RRR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Red Rock Resorts, Raises Price Target to $78 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on Red Rock Resorts (NASDAQ: RRR) and increased the price target from $77 to $78. This adjustment reflects the firm's positive outlook on the company's performance. https://openbell.ai/news/RIGL:1792421426810 2026-10-19T14:50:26.810Z daily 0.9 https://cdn.brandfetch.io/RIGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Rigel Pharmaceuticals (NASDAQ: RIGL) and maintained a price target of $85 for the stock. https://openbell.ai/news/NYXH:1792421292894 2026-10-19T14:48:12.894Z daily 0.9 https://cdn.brandfetch.io/NYXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nyxoah shares are trading lower after the company lowered its FY26 revenue guidance. openbell Financial News https://openbell.ai/news/DKI:1792421076706 2026-10-19T14:44:36.706Z daily 0.9 https://cdn.brandfetch.io/DKI/w/400/h/400?c=1idopYfmtR7ZKg8QMud DarkIris shares are trading lower after the company announced a 1-for-50 reverse stock split, effective October 22. openbell Financial News https://openbell.ai/news/MTCH:1792420920897 2026-10-19T14:42:00.897Z daily 0.9 https://cdn.brandfetch.io/MTCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Upgrades Match Group to Outperform, Raises Price Target to $53 Evercore ISI Group has upgraded Match Group (NASDAQ: MTCH) from In-Line to Outperform. The price target for the stock has been raised from $39 to $53, reflecting a positive outlook on the company's performance. https://openbell.ai/news/EVAX:1792420909509 2026-10-19T14:41:49.509Z daily 0.9 https://cdn.brandfetch.io/EVAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evaxion shares are trading higher after the company announced new three-year data showing durable responses and no tumor progression in its Phase 2 melanoma trial. openbell Financial News https://openbell.ai/news/DKNG:1792420855570 2026-10-19T14:40:55.570Z daily 0.9 https://cdn.brandfetch.io/DKNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on DraftKings, Raises Price Target to $30 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on DraftKings (NASDAQ: DKNG) and raised the price target from $29 to $30. This adjustment reflects a positive outlook on the company's performance in the market. https://openbell.ai/news/CHDN:1792420744831 2026-10-19T14:39:04.831Z daily 0.9 https://cdn.brandfetch.io/CHDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Churchill Downs, Raises Price Target to $120 Wells Fargo analyst Trey Bowers has maintained an Overweight rating on Churchill Downs (NASDAQ: CHDN) and increased the price target from $117 to $120. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/MRNA:1792420674858 2026-10-19T14:37:54.858Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpg?width=250&height=187 What's Going On With Moderna Stock Monday? Moderna Inc. (NASDAQ: MRNA) shares rose 4.40% to $227.61 as investors anticipate detailed Phase 3 melanoma data to be presented at the ESMO Congress on October 24. Bank of America increased its price target for the stock from $200 to $220 while maintaining a Neutral rating. The stock is rebounding after a nearly 10% drop from its 52-week high of $242.29, attributed to profit-taking following a 600% increase this year. Moderna is set to report its third-quarter results on November 6. https://openbell.ai/news/ANRO:1792420647176 2026-10-19T14:37:27.176Z daily 0.9 https://cdn.brandfetch.io/ANRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60 HC Wainwright & Co. analyst Patrick R. Trucchio has maintained a Buy rating on Alto Neuroscience (NYSE: ANRO) and raised the price target from $55 to $60. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/AMD:1792420571618 2026-10-19T14:36:11.618Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading higher as the sector rebounds from last week's weakness, with CoreWeave, the bellwether, rising on a Goldman Sachs upgrade. The Philadelphia Semiconductor Index is expected to end its longest losing streak since the 2008 financial crisis. openbell Financial News https://openbell.ai/news/IRON:1792420489581 2026-10-19T14:34:49.581Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Maintains Overweight on Disc Medicine, Raises Price Target to $170 Cantor Fitzgerald analyst Kristen Kluska has maintained an Overweight rating on Disc Medicine (NASDAQ: IRON) and raised the price target from $125 to $170. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/HII:1792420330521 2026-10-19T14:32:10.521Z daily 0.9 https://cdn.brandfetch.io/HII/w/400/h/400?c=1idopYfmtR7ZKg8QMud HII’s Ingalls Shipbuilding Division Receives $99M U.S. Navy Contract Modification To Carry Out See Trials For Zumwalt-Class Destroyer Lyndon B. Johnson HII's Ingalls Shipbuilding division has secured a $99 million contract modification from the U.S. Navy for conducting sea trials for the Zumwalt-class destroyer Lyndon B. Johnson (DDG 1002). The destroyer arrived at Ingalls in January 2022 for the installation, activation, and testing of its combat systems. https://openbell.ai/news/URGN:1792420269100 2026-10-19T14:31:09.100Z daily 0.9 https://cdn.brandfetch.io/URGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on UroGen Pharma (NASDAQ: URGN) and maintained a price target of $75 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/SPCX:1792420222810 2026-10-19T14:30:22.810Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Elon-Musk-is-the-founder--CEO--and-Chief.jpg?width=250&height=187 SpaceX Stock Moves Higher: What's Going On? SpaceX (NASDAQ: SPCX) shares rose 2.92% to $150.29 ahead of its third-quarter earnings report scheduled for October 20. Analysts expect the company to report $12.74 billion in revenue, a 63% increase from the previous quarter's $7.8 billion. In the second quarter, SpaceX's net loss decreased to $541 million from $1.0 billion, while adjusted EBITDA nearly tripled to $3.5 billion. RBC Capital maintains an Outperform rating with a price target of $225, citing positive momentum and potential merger discussions with Tesla.